{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:53:17Z","timestamp":1777578797890,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["DEC \/2011\/02\/A\/NZ4\/00031"],"award-info":[{"award-number":["DEC \/2011\/02\/A\/NZ4\/00031"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["DEC \/2014\/13\/N\/NZ7\/00897"],"award-info":[{"award-number":["DEC \/2014\/13\/N\/NZ7\/00897"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejphar.2020.173611","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T02:53:41Z","timestamp":1601607221000},"page":"173611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 \u2013 Triazine and 1H-indole like derivatives against the human histamine H4 receptor"],"prefix":"10.1016","volume":"890","author":[{"given":"Marek","family":"Grosicki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maristella","family":"Adami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Micheloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"G\u0142uch-Lutwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Siwek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gniewomir","family":"Latacz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"\u0141a\u017cewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Wi\u0119cek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Reiner-Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Stark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Chlopicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Kie\u0107-Kononowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173611_bib1","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173611_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/bbrc.2001.4976","article-title":"Structure and expression of the human histamine H4-receptor gene","volume":"284","author":"Cog\u00e9","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2020.173611_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0625.2011.01396.x","article-title":"Strain-dependent effects of the histamine H4 receptor antagonist JNJ7777120 in a murine model of acute skin inflammation","volume":"21","author":"Coruzzi","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejphar.2020.173611_bib4","first-page":"462","article-title":"The histamine H4 receptor as a new therapeutic target for inflammation","volume":"26","author":"De Esch","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2020.173611_bib5","series-title":"Drug-Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization, Drug-like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization","author":"Di","year":"2016"},{"key":"10.1016\/j.ejphar.2020.173611_bib6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ejmech.2012.06.016","article-title":"Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligands","volume":"54","author":"Engelhardt","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173611_bib7","series-title":"Substituted Nitrogen-Containing Heteroaryl Derivatives Useful as Modulators of the Histamine H4 receptor.WO2009035671 (A1)","author":"Gaul","year":"2009"},{"key":"10.1016\/j.ejphar.2020.173611_bib8","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1172\/JCI111570","article-title":"Leukotriene B4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells","volume":"74","author":"Gimbrone","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2020.173611_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2016.02.061","article-title":"In vitro study of histamine and histamine receptor ligands influence on the adhesion of purified human eosinophils to endothelium","volume":"777","author":"Grosicki","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173611_bib10","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1021\/jm0341047","article-title":"The first potent and selective non-imidazole human histamine H4 receptor antagonists","volume":"46","author":"Jablonowski","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173611_bib11","first-page":"637","article-title":"The involvement of adhesion molecules and lipid mediators in the adhesion of human platelets to eosinophils","volume":"56","author":"Jawie\u0144","year":"2005","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173611_bib12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejmech.2015.08.014","article-title":"(2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligands","volume":"103","author":"Kami\u0144ska","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173611_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/bph.12173","article-title":"Expression of histamine receptor genes Hrh3 and Hrh4 in rat brain endothelial cells","volume":"170","author":"Karlstedt","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173611_bib14","author":"Kita"},{"key":"10.1016\/j.ejphar.2020.173611_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejphar.2010.12.033","article-title":"Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3\/H4 receptor ligands","volume":"654","author":"Kottke","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173611_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/cbdd.12752","article-title":"The synthesis of 1,3,5-triazine derivatives and JNJ7777120 analogues with histamine H4 receptor affinity and their interaction with PTEN promoter","volume":"88","author":"Latacz","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejphar.2020.173611_bib47","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2174\/0929867323666160411143151","article-title":"Monocyclic and fused azines and azoles as histamine H4 receptor ligands","volume":"23","author":"\u0141a\u017cewska","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173611_bib46","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejmech.2014.06.032","article-title":"Aryl-1,3,5-triazine derivatives as histamine H4 receptor ligands","volume":"83","author":"\u0141a\u017cewska","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173611_bib48","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bmc.2019.02.020","article-title":"Alkyl derivatives of 1,3,5-triazine as histamine H4 receptor ligands","volume":"27","author":"\u0141a\u017cewska","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173611_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1476-5381.2009.00250.x","article-title":"Molecular and biochemical pharmacology of the histamine H4 receptor","volume":"157","author":"Leurs","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173611_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0705729","article-title":"Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation","volume":"142","author":"Ling","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173611_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-3565(24)29309-5","article-title":"Comparison of human, mouse, rat, and Guinea pig histamine H4 receptors reveals substantial pharmacological species variation","volume":"299","author":"Liu","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173611_bib20","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.3390\/molecules24244472","article-title":"Are the hydantoin-1,3,5-triazine 5-HT6R ligands a hope to a find new procognitive and anti-obesity drug? Considerations based on primary in vivo assays and ADME-tox profile in vitro","volume":"24","author":"Lubelska","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2020.173611_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/CMR.0b013e328347ee53","article-title":"Role of H4 receptor in histamine-mediated responses in human melanoma","volume":"21","author":"Massari","year":"2011","journal-title":"Melanoma Res."},{"key":"10.1016\/j.ejphar.2020.173611_bib22","doi-asserted-by":"crossref","first-page":"26471","DOI":"10.18632\/oncotarget.15594","article-title":"Histamine therapeutic efficacy in metastatic melanoma: role of histamine H4 receptor agonists and opportunity for combination with radiation","volume":"8","author":"Massari","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2020.173611_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrd.2017.111","article-title":"Opportunities and challenges in phenotypic drug discovery: an industry perspective","volume":"16","author":"Moffat","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2020.173611_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00011-016-0997-z","article-title":"Aryl-1,3,5-triazine ligands of histamine H4 receptor attenuate inflammatory and nociceptive response to carrageen, zymosan and lipopolysaccharide","volume":"66","author":"Mogilski","year":"2017","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2020.173611_bib25","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-3565(24)38851-2","article-title":"Cloning and characterization of a novel human histamine receptor","volume":"296","author":"Morse","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173611_bib26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1006\/bbrc.2000.4008","article-title":"Molecular cloning and characterization of a new human histamine receptor","volume":"279","author":"Nakamura","year":"2000","journal-title":"HH4R. Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2020.173611_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0026-895X(24)12231-6","article-title":"Discovery of a novel member of the histamine receptor family","volume":"59","author":"Nguyen","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173611_bib28","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1016\/j.bmcl.2007.05.041","article-title":"Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2","volume":"17","author":"Nie","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2020.173611_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/bph.12117","article-title":"Detailed analysis of biased histamine H\u2084 receptor signalling by JNJ 7777120 analogues","volume":"170","author":"Nijmeijer","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173611_bib30","doi-asserted-by":"crossref","first-page":"36781","DOI":"10.1074\/jbc.M006480200","article-title":"Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes","volume":"275","author":"Oda","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173611_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1081\/RRS-120014612","article-title":"Identification of a histamine H4 receptor on human eosinophils--role in eosinophil chemotaxis","volume":"22","author":"O\u2019Reilly","year":"2002","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.ejphar.2020.173611_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/pr.114.010249","article-title":"International union of basic and clinical pharmacology. XCVIII. Histamine receptors","volume":"67","author":"Panula","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2020.173611_bib33","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1111\/bph.14185","article-title":"Antinociceptive effects of novel histamine H3 and H4 receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse","volume":"175","author":"Popio\u0142ek-Barczyk","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173611_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bcp.2012.04.004","article-title":"Incomplete activation of human eosinophils via the histamine H4-receptor: evidence for ligand-specific receptor conformations","volume":"84","author":"Reher","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173611_bib35","article-title":"Modulation of behavior by the histaminergic system: lessons from HDC-, H3R- and H4R-deficient mice","author":"Schneider","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2020.173611_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2008.11.018","article-title":"Localization of histamine H4 receptors in the central nervous system of human and rat","volume":"1250","author":"Strakhova","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2020.173611_bib37","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1016\/j.bmcl.2004.08.035","article-title":"Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H4 receptor antagonists","volume":"14","author":"Terzioglu","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2020.173611_bib38","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1124\/jpet.103.061754","article-title":"A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties","volume":"309","author":"Thurmond","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173611_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2465","article-title":"The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines","volume":"7","author":"Thurmond","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2020.173611_bib40","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1021\/jm0502081","article-title":"Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine H4 antagonists","volume":"48","author":"Venable","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173611_bib41","first-page":"4175","article-title":"Anti-breast cancer activity of selected 1,3,5-triazines via modulation of EGFR-TK","volume":"18","author":"Weixin","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2020.173611_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1476-5381.2009.00151.x","article-title":"The role of histamine H4 receptor in immune and inflammatory disorders","volume":"157","author":"Zampeli","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173611_bib43","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.pharmthera.2006.11.008","article-title":"The histamine H4 receptor: a novel modulator of inflammatory and immune disorders","volume":"113","author":"Zhang","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2020.173611_bib44","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.drudis.2013.07.001","article-title":"Phenotypic screens as a renewed approach for drug discovery","volume":"18","author":"Zheng","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2020.173611_bib45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0026-895X(24)12232-8","article-title":"Cloning, expression, and pharmacological characterization of a novel human histamine receptor","volume":"59","author":"Zhu","year":"2001","journal-title":"Mol. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920307032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920307032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:35:38Z","timestamp":1777404938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920307032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":48,"alternative-id":["S0014299920307032"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173611","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 \u2013 Triazine and 1H-indole like derivatives against the human histamine H4 receptor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173611"}}